SCHEMBL5768348

SCHEMBL5768348

CCCN(CCC)c1ccc2c(c1)OC(C(F)(F)F)C(C(=O)OCC)=C2

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.45
PTGS1 P23219 16/20 0.45
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5644742 0.91 PTGS2 (0.46) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5645364 0.84 PTGS2 (0.56) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5643820 0.83 PTGS2 (0.52) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5645501 0.83 PTGS2 (0.49) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5646373 0.83 PTGS2 (0.49) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5646523 0.82 PTGS2 (0.52) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5770246 0.82 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL20825823 0.82 PTGS2 (0.48) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL5646242 0.82 PTGS2 (0.48) PTGS2PTGS1NFKB1NFKB2RELA
SCHEMBL27900973 0.82 PTGS2 (0.48) PTGS2PTGS1NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631562-A1 CHROMENE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS Pharmacia Corporation (US) 2006-03-08 EP disclosed
EP-1615905-A2 BENZOPYRAN COMPOUNDS USEFUL FOR TREATING INFLAMMATORY CONDITIONS Pharmacia Corporation (US) 2006-01-18 EP disclosed
WO-2004087687-A1 CHROMENE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS PHARMACIA CORPORATION (US) 2004-10-14 WO disclosed
WO-2004087686-A2 BENZOPYRAN COMPOUNDS USEFUL FOR TREATING INFLAMMATORY CONDITIONS PHARMACIA CORPORATION (US) 2004-10-14 WO disclosed